Stock 002773 CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Chengdu Kanghong Pharmaceutical Group Co., Ltd

Equities

002773

CNE1000020C4

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
22.71 CNY +0.66% Intraday chart for Chengdu Kanghong Pharmaceutical Group Co., Ltd -4.02% +23.16%
Apr. 29 Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug MT
Apr. 29 Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug MT

Business Summary

Chengdu Kanghong Pharmaceutical Group Co., Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines, chemical drugs and biological products. The Company’s main products include Conbercept Ophthalmic Injection, Songling capsules conducive to blood vessels, Keluoxin capsules, venlafaxine hydrochloride capsules and sustained release tablets, aripiprazole tablets and orally disintegrating tablets, mosapride citrate tablets and dispersible tablets, dexzopiclone tablets, Shuganjieyu capsules, Danshu capsules and Yiqing capsules, among others. The Company distributes its products in domestic market.

Number of employees: 4,289

Sales per Business

CNY in Million2022Weight2023Weight Delta
Biological Products
48.9 %
1,366 40.3 % 1,936 48.9 % +41.73%
Chinese Patent Medicine
33.2 %
1,169 34.5 % 1,313 33.2 % +12.33%
Chemical Medicine
17.5 %
834 24.6 % 693 17.5 % -16.84%
Medical Device
0.3 %
16 0.5 % 12 0.3 % -28.25%
Others
0.1 %
3 0.1 % 2 0.1 % -25.85%
Other Business
0.0 %
1 0.0 % 1 0.0 % -1.40%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.8 %
3,382 99.8 % 3,949 99.8 % +16.75%
Overseas
0.2 %
6 0.2 % 8 0.2 % +31.59%
Global
0.0 %
1 0.0 % 1 0.0 % -1.40%

Managers

Managers TitleAgeSince
Jian Jun Zhong DFI
 Director of Finance/CFO 57 -
Xiao Ke PSD
 President 41 11-12-31
Jin Qun Yin BRD
 Director/Board Member 52 13-06-20
Yin Ying Yang BRD
 Director/Board Member 38 16-09-18
Jian Qun Yang BRD
 Director/Board Member 50 19-12-26
Jian Rong Zhong BRD
 Director/Board Member 67 11-12-31
Kang Deng IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Jian Rong Zhong BRD
 Director/Board Member 67 11-12-31
Zun Hong Ke CHM
 Chairman 70 97-12-31
Xiao Ke PSD
 President 41 11-12-31
Wen Xian Gong CHM
 Chairman 77 11-12-31
Jian Qun Yang BRD
 Director/Board Member 50 13-06-20
Jian Jun Zhong DFI
 Director of Finance/CFO 57 -
Yu Zhang BRD
 Director/Board Member 46 16-09-18
San Cai Qu BRD
 Director/Board Member 50 16-09-18
Jin Qun Yin BRD
 Director/Board Member 52 13-06-20
Qiang Zhang BRD
 Director/Board Member 66 19-12-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 919,463,954 263,179,706 ( 28.62 %) 0 28.62 %

Shareholders

NameEquities%Valuation
Xiao Ke
45.17 %
312,079,899 45.17 % 935 M ¥
Zun Hong Ke
7.516 %
51,931,605 7.516 % 156 M ¥
Jing Gong
4.802 %
33,177,779 4.802 % 99 M ¥
China Southern Asset Management Co., Ltd.
1.932 %
13,347,316 1.932 % 40 M ¥
Xing Ping Zhao
1.350 %
9,328,616 1.350 % 28 M ¥
GF Fund Management Co., Ltd.
0.9528 %
6,582,949 0.9528 % 20 M ¥
Wen Hua Liu
0.8439 %
5,831,000 0.8439 % 17 M ¥
Zhi Rong Zhang
0.5804 %
4,010,000 0.5804 % 12 M ¥
Yu Rong Zhou
0.4845 %
3,347,440 0.4845 % 10 M ¥
HFT Investment Management Co., Ltd.
0.4753 %
3,284,000 0.4753 % 10 M ¥
NameEquities%Valuation
Zun Hong Ke
67.32 %
155,794,814 67.32 % 467 M ¥
Xiao Ke
26.01 %
60,194,999 26.01 % 180 M ¥
Jian Rong Zhong
3.429 %
7,934,609 3.429 % 24 M ¥
Jian Jun Zhong
3.031 %
7,015,341 3.031 % 21 M ¥
Zhi Rong Zhang
1.300 %
3,007,500 1.300 % 9 M ¥

Company contact information

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

108 Shuxi Road Jinniu District

610037, Chengdu

+

http://www.cnkh.com
address Chengdu Kanghong Pharmaceutical Group Co., Ltd(002773)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Chengdu Kanghong Pharmaceutical Group Co., Ltd

Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
22.71
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD Stock Chengdu Kanghong Pharmaceutical Group Co., Ltd
+23.16% 2.89B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002773 Stock
  4. Company Chengdu Kanghong Pharmaceutical Group Co., Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW